A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period

Transfusion

Volumn 48, Issue 8, 2008, Pages 1602-1608

  Wendel, Silvano ^a   Levi, José E ^b   Biagini, Silvana ^b   Candotti, Daniel ^b   Allain, Jean Pierre ^b  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY;

ACUTE HEPATITIS; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; ERYTHROCYTE TRANSFUSION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; SCHOOL CHILD; SEROCONVERSION; THROMBOCYTE TRANSFUSION; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS TRANSMISSION;

ACUTE DISEASE; BLOOD DONORS; BLOOD TRANSFUSION; CHILD; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TIME FACTORS;

EID: 48249140697     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01723.x     Document Type: Article

References (22)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996 334 : 1685 90.
2. Roth WK, Weber M, Petersen D, Drosden C, Buhr S, Sireis W, Weichert W, Hedges D, Seifried E. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002 42 : 869 75.
3. Meng Q, Wong C, Rangachari A, Tamatsukuri S, Sasaki M, Fiss E, Cheng L, Ramankutty T, Clarke D, Yawata H, Sakakura Y, Hirose T, Impraim C. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA. J Clin Microbiol 2001 39 : 2937 45.
4. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain J-P, Letowska M. Characterization of HBV DNA positive/HBsAg negative blood donors identified in the Polish NAT screening program. Hepatology 2006 44 : 1666 74.
5. Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP. Pre-donation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005 45 : 133 40.
6. Wendel S, Levi JE, Takaoka DT, Silva IC, Castro JP, Torezan-Filho MA, Ghaname J, Gioachini R, Durigon EL. Primary screening of blood donors by NAT testing for HCV-RNA: development of an "in-house" method and results. Rev Inst Med Trop Sao Paulo 2007 49 : 177 85.
7. Mimms L, Mosley JW, Hollinger FB, Aach RD, Stevens CE, Cunningham M, Vallari DV, Barbosa LH, Nemo GJ. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 1993 307 : 1095 7.
8. Yokosuka O, Tagawa M, Omata M. PCR detection of hepatitis B virus. In : Persing D, editor. Diagnostic molecular microbiology, principles and applications. Washington, DC : ASM Press 1993. p. 2 3.
9. Allain JP, Candotti D, Soldan K, Sarkodie F, Phelps B, Giachetti C, Shyamala V, Yeboah F, Anokwa M, Owusu-Ofori S, Opare-Sem O. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 2003 101 : 2419 25.
10. Candotti D, Opare-Sem O, Rezvan H, Sarkodie F, Allain JP. Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine amino transferase. J Viral Hepat 2006 13 : 715 24.
11. Barker LF, Murray R. Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis-associated antigen. Am J Med Sci 1972 263 : 27 33.
12. Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, David MF, Arulnaden JL, Bismuth A, Reynes M, Bismuth H. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1997 26 : 517 26.
13. Prince AM, Lee DH, Brotman B. Infectivity of blood from PCR positive, HBsAg negative, anti-HBs-positive cases of resolved hepatitis B infection. Transfusion 2001 41 : 329 32.
14. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995 20 : 992 1000.
15. Motta-Castro AR, Martins RM, Yoshida CF, Teles SA, Panago AM, Lima KM, Gomes SA. Hepatitis B virus infection in isolated Afro-Brazilian communities. J Med Virol 2005 77 : 188 93.
16. Araujo NM, Mello FC, Yoshida CF, Niel C, Gomes SA. High proportion of subgroup A' (genotype A) among Brazilian isolates of hepatitis B virus. Arch Virol 2004 149 : 1383 95.
17. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 98.
18. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 2004 44 : 1332 9.
19. Yoshikawa A, Gotanda Y, Itabashi M, Mineshigi K, Kanemitsu K, Nishioka K. Hepatitis B NAT virus-positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang 2005 88 : 77 86.
20. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Misoguchi H. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 2007 47 : 1162 71.
21. Gerlich WH, Wagner FF, Chudy M, Harrishoj LH, Lattermenn A, Wienzek S, Glebe D, Sanievski M, Schuttler CG, Wend UC, Willems WR, Bauerfeind U, Jork C, Bein G, Platz P, Ullum H, Dickmeiss E. HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol 2007 79 : S32 S36.
22. Tabor E. Infections by hepatitis B surface antigen gene mutants in Europe and North America. J Med Virol 2006 78 : S43 S47.